Naviter Wealth LLC bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 38,061 shares of the real estate investment trust's stock, valued at approximately $771,000.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. QRG Capital Management Inc. bought a new position in Healthpeak Properties during the 3rd quarter worth $565,000. Amalgamated Bank bought a new position in Healthpeak Properties during the third quarter worth about $3,167,000. Concurrent Investment Advisors LLC acquired a new stake in Healthpeak Properties in the 3rd quarter worth about $210,000. Principal Financial Group Inc. acquired a new stake in Healthpeak Properties in the 3rd quarter worth about $18,736,000. Finally, AIA Group Ltd bought a new stake in Healthpeak Properties in the 3rd quarter valued at about $293,000. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Price Performance
DOC stock traded down $0.12 during trading on Wednesday, reaching $20.21. 3,754,869 shares of the company were exchanged, compared to its average volume of 4,735,405. The company has a market capitalization of $14.13 billion, a price-to-earnings ratio of 57.73, a P/E/G ratio of 2.17 and a beta of 1.14. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The company has a 50-day moving average of $20.21 and a two-hundred day moving average of $21.27. Healthpeak Properties, Inc. has a twelve month low of $16.66 and a twelve month high of $23.26.
Healthpeak Properties Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were paid a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.04%. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 14th. Healthpeak Properties's dividend payout ratio is presently 348.57%.
Analyst Ratings Changes
Several brokerages have recently commented on DOC. Robert W. Baird lowered their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Tuesday, February 11th. Scotiabank lowered their price objective on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a research note on Friday, February 28th. Wells Fargo & Company cut their target price on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 10th. Wedbush decreased their price target on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating on the stock in a research report on Friday, February 14th. Finally, Morgan Stanley raised Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 price target for the company in a research note on Wednesday, January 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $23.92.
Check Out Our Latest Stock Report on Healthpeak Properties
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.